← FDA Drug Approvals (Drugs@FDA)

ABACAVIR SULFATE; LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MATRIX LABS LTD · Approved 2009-03-30

Drug application

FDA Application #

ANDA090519

Application type

Abbreviated New Drug Application (Generic)

Brand name

ABACAVIR SULFATE; LAMIVUDINE

Generic name

Abacavir Sulfate

Active ingredients

ABACAVIR SULFATE; LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

MATRIX LABS LTD

First approval

2009-03-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown